CARE IPO Analysis

Reasonable Valuation | Strong Profitability | Long-Term Business Visibility

IPO Overview

Credit Analysis & Research (CARE) has launched its Initial Public Offering (IPO) through a pure Offer for Sale (OFS).

The issue consists of 7,199,700 equity shares of face value ₹10 each.
The price band is fixed at ₹700–₹750 per share, aiming to raise up to ₹540 crore.

• Issue opens: December 7, 2012

• Issue closes: December 11, 2012

Importantly, since this is an OFS, the company will not receive any proceeds.
All proceeds will go to the existing shareholders.

Company Profile

CARE is the second-largest full-service credit rating company in India.

It provides rating and grading services across multiple instruments and industries.
Over the years, the company has built a strong institutional presence.

Key Services Offered

• Credit ratings for debt instruments

• Ratings for bank loans and credit facilities

• IPO grading and equity grading

• Enterprise and project grading, including:

  • Real estate

  • Construction companies

  • Shipyards

  • Maritime training institutes

As of the offer date, CARE had 4,644 active clients.
These clients span manufacturing, services, banking, and infrastructure sectors.

Business Strengths

CARE benefits from a high-quality and scalable business model.

Key Positives

• Strong brand credibility in credit ratings

• Deep sector knowledge across industries

• Stable and highly profitable operations

• Debt-free balance sheet

• Strong cash generation and return ratios

Moreover, the rating industry has high entry barriers.
Regulatory oversight and long-term client relationships further strengthen the moat.

Key Risks and Concerns

However, investors should also consider the risks.

Risk Factors to Note

• High dependence on rating services for revenue

• New business diversification may impact margins initially

• Possible impact from banks shifting to IRB-based internal ratings

• Retention risk of skilled professionals

• Limited operating experience outside India

These risks are typical for the credit rating and financial services industry.

Valuation Analysis

Based on FY12 EPS of ₹40.52, valuation appears reasonable.

• P/E at ₹700: ~17.3×

• P/E at ₹750: ~18.5×

Peer Comparison (TTM P/E)

• ICRA: ~24.8×

• CRISIL: ~37.8×

In contrast, CARE is offered at a clear discount to peers.
This is despite similar business quality and profitability.

Industry Outlook

Looking ahead, the sector outlook remains favourable.

The credit rating industry should benefit from:

• Growth in corporate bond markets

• Increased focus on credit transparency

• Rising demand for ratings across products

• Expansion in infrastructure financing

Additionally, CARE’s diversification plans and global ambitions could support long-term growth, subject to execution discipline.

Financial Performance Summary

(₹ in millions)

Investment View

Overall, CARE appears reasonably valued at the IPO price band.

Key positives include:

• Debt-free structure

• High profitability

• Strong return ratios

• Favorable industry tailwinds

That said, investors should remember that this is an Offer for Sale.
Future returns will depend on earnings growth and regulatory stability.

Long-Term Perspective

From a long-term portfolio standpoint, CARE represents a stable financial services franchise.

It suits investors seeking:

• Consistent profitability

• Strong cash flows

• Moderate risk exposure

Allocation should, however, align with individual risk appetite.

Disclaimer

This article is for educational and informational purposes only.
It does not constitute investment advice or a recommendation.

Equity investments are subject to market risks.
Investors should read the offer document carefully and consult their financial advisor before investing.